Data / Form D filings / BioIntelliSense, Inc.
BioIntelliSense, Inc.: Form D filings
BioIntelliSense, Inc., a company in Golden, CO, filed 5 Form D notices with the SEC between 2020 and 2026. The latest, on June 4, 2026, reports $58.3 million sold of a $58.4 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 17301 W. COLFAX AVENUE SUITE 152, Golden, CO, 80401
- Phone
- (720) 689-9008
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1824134
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Amendment | $58,350,027 | $58,349,365 | $662 | 14 | Dec 4, 2025 | sec.gov |
| Dec 19, 2025 | New notice | $58,350,027 | $58,050,027 | $300,000 | 4 | Dec 4, 2025 | sec.gov |
| Sep 15, 2022 | New notice | $44,985,854 | $44,985,854 | 16 | Apr 7, 2021 | sec.gov | |
| Sep 10, 2020 | New notice | $12,000,003 | $12,000,003 | 11 | Aug 20, 2020 | sec.gov | |
| Sep 10, 2020 | New notice | $25,000,000 | $24,997,665 | $2,335 | 22 | Dec 14, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Wang | Executive Officer, Director | |
| James Mault | Executive Officer, Director | |
| Conlan Ma | Director | |
| Xinyaun Yu | Director |
Other companies in Colorado that filed recently
- Faex Technologies Inc. $2.5 million · Oct 29, 2026
- Bios US LP $1 million · Oct 28, 2026
- Crimson Circle Energy Company, Inc. offering · Oct 23, 2026
- Youtopia Marketplace, LLC $4.4 million · Oct 19, 2026
- Martin/Martin, Inc. offering · Oct 19, 2026
- authID Inc. $1.4 million · Oct 16, 2026
Every Form D from the week of Jun 1, 2026 · All recent filings in Colorado · All recent Other filings
Read from SEC EDGAR. Amount sold is what BioIntelliSense, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.